Adverse events
gastro-intestinal bleeding, osteonecrosis
OSTEONECROSIS, ADVERSE EVENT, DIABETES MELLITUS, BLOOD, ARTERIAL HYPERTENSION
Overall, the 24-month treatment with budesonide was well tolerated (Table Adverse events.In addition, there were no patients with new-onset diabetes mellitus, gastro-intestinal bleeding, osteonecrosis or worsening of preexisting arterial hypertension. The blood glucose levels and mean arterial pressures remained stable throughout the study period (Fig. Blood glucose and mean arterial pressure evolution.